Patient-derived organoids

Dr. Alysson Muotri from UCSD has generated organoids from patient-derived iPSC and isogenic controls and these organoids display growth and survival phenotypes, as well as a deficiency in production of hypusine. This model is useful for compound and gene therapy evaluation.